Altimmune (ALT) Dividends payables (2016)
Altimmune's (ALT) quarterly Dividends payables came in at $197.1 million in Q4 2016.
Altimmune (ALT) Dividends payables (2016) Analysis & Trends
Altimmune (ALT) has 1 years of Dividends payables data on file, last reported at $197.1 million in Q4 2016.
- On a quarterly basis, Dividends payables changed N/A year-over-year to $197.1 million in Q4 2016; TTM through Dec 2016 was $197.1 million, a N/A change from a year earlier, with the FY2016 full-year figure at $197.1 million, changed N/A from the prior year.
- Dividends payables for Q4 2016 stood at $197.1 million.
- Over the last five years, Dividends payables for ALT reached as high as $197.1 million in Q4 2016 and fell as low as $197.1 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 197.08 Mn |